Longo R - Search Results

1

Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer.

Landriscina M, Cassano A, Ratto C, Longo R, Ippoliti M, Palazzotti B, Crucitti F, Barone C. Landriscina M, et al. Among authors: longo r. Br J Cancer. 1998 Sep;78(6):765-70. doi: 10.1038/bjc.1998.575. Br J Cancer. 1998. PMID: 9743297 Free PMC article.

2

Tailored therapy of colorectal cancer: results, challenges and future directions.

Gasparini G, Longo R, Torino F, Barone C, Toffoli G. Gasparini G, et al. Among authors: longo r. Cancer J. 2005 May-Jun;11(3):175-88. doi: 10.1097/00130404-200505000-00002. Cancer J. 2005. PMID: 16053659 Review.

3

Bolus and infusional 5-fluorouracil combined with cisplatin in advanced gastric cancer.

Barone C, Cassano A, Landriscina M, Longo R, Astone A, Pozzo C. Barone C, et al. Among authors: longo r. Oncol Rep. 2000 Nov-Dec;7(6):1305-9. doi: 10.3892/or.7.6.1305. Oncol Rep. 2000. PMID: 11032934 Clinical Trial.

4

Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.

Barone C, Cassano A, Pozzo C, D'Ugo D, Schinzari G, Persiani R, Basso M, Brunetti IM, Longo R, Picciocchi A. Barone C, et al. Among authors: longo r. Oncology. 2004;67(1):48-53. doi: 10.1159/000080285. Oncology. 2004. PMID: 15459495 Clinical Trial.

5

Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.

Barone C, Cassano A, Corsi DC, Pozzo C, Longo R, Schinzari G, Quirino M, Battelli C, Basso M. Barone C, et al. Among authors: longo r. Oncology. 2003;64(2):139-45. doi: 10.1159/000067775. Oncology. 2003. PMID: 12566911 Clinical Trial.

6

Challenges for patient selection with VEGF inhibitors.

Longo R, Gasparini G. Longo R, et al. Cancer Chemother Pharmacol. 2007 Jul;60(2):151-70. doi: 10.1007/s00280-006-0403-6. Epub 2007 Mar 17. Cancer Chemother Pharmacol. 2007. PMID: 17370072 Review.

7

Prognostic and predictive indicators in operable breast cancer.

Morabito A, Magnani E, Gion M, Sarmiento R, Capaccetti B, Longo R, Gattuso D, Gasparini G. Morabito A, et al. Among authors: longo r. Clin Breast Cancer. 2003 Feb;3(6):381-90. doi: 10.3816/CBC.2003.n.002. Clin Breast Cancer. 2003. PMID: 12636883 Review.

8

Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical course.

Longo R, Morabito A, Carillio G, Lanzi G, Castellana MA, Amici S, Fanelli M, Gattuso D, Gasparini G. Longo R, et al. Int J Gastrointest Cancer. 2006;37(1):49-54. doi: 10.1385/IJGC:37:1:49. Int J Gastrointest Cancer. 2006. PMID: 17290081

9

Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer.

Morabito A, Carillio G, Longo R, Gasparini G. Morabito A, et al. Among authors: longo r. Cancer J. 2005 May-Jun;11(3):248-51. doi: 10.1097/00130404-200505000-00012. Cancer J. 2005. PMID: 16053669 Clinical Trial.

10

Angiogenic inhibitors: a new therapeutic strategy in oncology.

Gasparini G, Longo R, Toi M, Ferrara N. Gasparini G, et al. Among authors: longo r. Nat Clin Pract Oncol. 2005 Nov;2(11):562-77. doi: 10.1038/ncponc0342. Nat Clin Pract Oncol. 2005. PMID: 16270097 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

495 results

Search Page

Filters